Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Echinobase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Echinobase
ECB-ART-50874
Nanomedicine (Lond) 2022 Aug 01;1720:1477-1499. doi: 10.2217/nnm-2022-0096.
Show Gene links Show Anatomy links

Formulation and clinical advancement of nanourchins: a novel multibranched nanoparticulate drug-delivery system.

Joshi A , Agrawal A , Bhattacharya S .


???displayArticle.abstract???
Nanourchins are multibranched nanoparticles with unique optical properties and surface spikes. Because of their unique properties, gold nanourchins have advantages over gold nanoparticles. The most used nanourchins are gold, tungsten, carbon, vanadium and sea urchins. The synthesis of various nanourchins and their clinical advancement are discussed in this review. ZFNs, TALENs and CRISPR/Cas9 are discussed to facilitate understanding of advancements in nanourchins. Nanourchins have been studied for Parkinson's disease, Alzheimer's disease and bioimaging. The synthesis of molybdenum diselenide nanourchins and their bioconjugations are also discussed. Nanourchins can be further explored to improve drug targeting and delivery. Researchers from several fields may contribute to the study of nanourchins as prospective nanocarriers with target specificity.

???displayArticle.pubmedLink??? 36154464
???displayArticle.link??? Nanomedicine (Lond)